How many patents does
Nycomed have?
patents
1,518
families
148
granted
561
applications
957
US
264
EP
124
CN
66
JP
31
WO
26
KR
17
RoW
990
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Nycomed
Top ten assignees appearing on patents
2009 - 2018
| nycomed | 848 |
| takeda | 336 |
| altana pharma | 82 |
| 4sc | 71 |
| nps pharmaceuticals | 61 |
| astrazeneca | 25 |
| shire-nps pharmaceuticals | 19 |
| nycomed asset management | 7 |
| nycomed germany holding | 7 |
| kist, michel | 7 |
Nycomed
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| treatment of short bowel syndrome patients with colon-in-continuity | 64 | 2004 |
| hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors | 61 | 2004 |
| combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the … 🛈 | 55 | 2006 |
| pyrazolone derivatives as pde4 inhibitors | 50 | 2007 |
| ophthalmological use of roflumilast for the treatment of diseases of the eye | 50 | 2002 |
| oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrro… 🛈 | 40 | 2002 |
| 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4, 3-c] isoquinoline derivatives | 39 | 2009 |
| dosage form containing pantoprazole as active ingredient | 38 | 2003 |
| methylpyrrolopyrimidinecarboxamides | 34 | 2009 |
| novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives | 34 | 2005 |